Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedUpgrade to v3.2.0 with a government funding notice and NIH Clinical Center operating details; removes v3.1.0 reference.SummaryDifference4%

- Check25 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check40 days agoChange DetectedUpdated to v3.0.2 (from v3.0.1); removed the Back to Top link.SummaryDifference0.2%

- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%

- Check54 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to cancer treatments such as immunotherapy and radiotherapy. Notably, previous references to specific locations and certain cancer-related terms have been removed.SummaryDifference2%

- Check69 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.